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ABSTRACT 
The aim of this study was to synthesize, characterization and thrombolytic activity of    N-Benzyl piperidin 4-one phenyl hydrazone derivative. 
Check the purity of all the synthesized compounds using thin layer chromatography. The synthesized compound was characterized by IR, 13C and 
1H NMR spectral studies. The synthesized compound was subjected to thrombolytic activity. The thrombolytic activity was observed in 2 
different concentrations of N-Benzyl piperidin 4-one phenyl hydrazone. Our findings support the reported therapeutic use of this compound as a 
thrombolytic agent in the Indian system of medicine. 
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INTRODUCTION 
Aromatic hetero cyclic chemistry is an enormous and 
complex subject of great industrial and academic 
significance. A number of molecules of life are derived from 
aromatic heterocycles and many pharmaceutical and 
agrochemical compounds are based on aromatic 
Heterocycles. A cyclic aromatic compound containing all C-
atoms in ring formation is referred to as a carboxylic 
compound. If at least one atom other than carbon form a part 
of ring system then it is designated as a heterocyclic 
compound. Organic chemistry and medicinal chemistry are 
becoming very vital chemistry. The primary objective of an 
organic chemist is to work towards isolation, 
characterization and synthesis of new compounds that are 
suitable for use as drugs. Medicinal or pharmaceutical 
chemistry is a discipline at the intersection of chemistry and 
pharmacology involved with designing, synthesizing and 
developing pharmaceutical drugs. However their derivatives 
having N-C linkage have been used in the fields of medicinal 
and pharmaceutical chemistry and reported to exhibit a 
variety of biological activities1-4. Hydrazones and their 
derivatives constitute an important class of compounds that 
has found wide utility in organic synthesis. The chemistry of 
carbon-nitrogen double bond of hydrazone is becoming the 
backbone of condensation reaction in benzo-fused N-
heterocyclics also it constitutes an important class of 
compounds for new drug development. 
Thrombolytic drugs are widely used for the management of 
cerebral venous sinus thrombosis patients. Several in vitro 
models have been developed to study clot lytic activity of 
thrombolytic drugs, but all of these have certain limitations. 
There is need of an appropriate model to check the clot lytic 
efficacy of thrombolytic drugs. In the present study, an 
attempt has been made to design and develop a new model 
system to study clot lysis in a simplified and easy way using a 
thrombolytic drug, streptokinase.5 
MATERIALS AND METHODS 
All the chemicals (solvents and reagents) were purchased 
from foreign companies (Hi-media and Sigma/Aldrich) and 
were used as such with no further purification and 
distillation. Local chemical has not been used in the research 
work. The purity of these chemicals was 98-99.9%. The 
hydroxyl amine hydrochloride (Hi-media sigma/Aldrich) 
was used as received. The other reagents used were sodium 
acetate and sodium hydroxide (Merck). Analytical grade 
solvents like ethanol, methanol, ethyl acetate, chloroform 
(CHCl3) and N-hexane were used as such without further 
distillation. The synthesized compounds were scaled for 
yield and purified by recrystallization with suitable solvent 
system.  
IR spectra were recorded in AVATAR-330 FT-IR 
spectrophotometer (Thermo Nicolet) and only noteworthy 
absorption levels (reciprocal centimeters) are listed. 1H NMR 
spectra were recorded on BRUKER AMX 300 MHz and 300 
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MHz NMR recorded on a BRUKER AMX 300 MHz NMR 
spectrometer operating at 100 MHz. For recording 1H NMR 
spectrum of compound solution were prepared by dissolving 
about 10mg of the compound in 0.5 ml of CDCl3 was used as 
solvent while for 13C NMR spectra, about 50 mg of the 
compound was dissolved in the same volume of the 
respective solvents. TMS (Tetra methyl silane) was used as a 
internal standard. 
Preparation of N-benzyl piperidin-4-one phenyl 
hydrazone 
To the boiling solution of N-benzyl piperdine-4-one 
(0.01mol) in methanol (45ml) and few drops of concentrated 
hydrochloric acid, the methanolic solution of  phenyl 
hydrazine hydrochloride (0.01mol)  was added dropwise by 
stirring.The reaction was refluxed for 4 hrs on a water both. 
After cooling the solid product was filtered and 
recrystallized methanol to get the corresponding phenyl 
hydrazone. 
In vitro thrombolytic activity 
Thrombolytic activity determined by the method of Fatema 
Tabassum et al(2017). 6-7 
Preparation of streptokinase (SK)  
About 5 ml sterile distilled water was added to the 
commercially available lyophilized SK vial of 15,00,000 I.U. 
and mixed properly. This suspension was used as a stock 
from which 100 μl (30,000 I.U) was used for in vitro 
thrombolysis study. 
Collection of blood 
Whole blood was drawn from healthy human volunteers 
without a history of oral contraceptives or anticoagulant 
therapy and 1 ml of blood was transferred to the previously 
weighted sterile eppendorf tubes and was allowed to form 
clots. 
Procedure 
3ml venous blood drawn from own blood was distributed in 
four different pre- weighted eppendorf tube and incubated at 
370 c for 45minutes. After clot formation, serum was 
completely removed without disturbing the clot and each 
tube having clot was again weighed to determine the clot 
weight (clot weight = weight of clot containing tube-
weight of tube alone). To each eppendorf tube containing 
pre-weighted clot, 100µl (100μg/ml) of sample was added 
and another eppendorf tube containing pre-weighted clot, 
200µl (200μg/ml) of sample was added. As a negative 
control, 100µl of distilled water was added to the control 
tube. For positive control, 100µl of streptokinase (SK) was 
added. All the tubes were then incubated at 370C for 
90minutes and observed for clotlysis. After incubation, fluid 
released was removed and tubes were again weighted to 
observe the difference in weight after clot disruption. 
Difference obtained in weight taken before and after clot 
lysis was expressed as percentage of clotlysis. The equation 
for calculating weight of clot is given below. 
Clot weight = Weight of clot filled tube –Weight of empty tube 
                  
                                 
                            
     
 
RESULTS AND DISCUSSION 
Table 1: Analytical   and   spectral data of N-benzyl piperidin-4-one phenyl hydrazone 
 
MF: C18H21N3 
 
 M.Pt.163-1650C 
 
Yield (%):86 
 
IR (cm-1): 3195,3113 (N-H stretching); 2915-2689 (C-H stretching); 1597 (C=N stretching); 
1495 (C=C stretching-phenyl); 1328, 1239 (aromatic amine C-N); 1166. 
1H NMR (δ ppm) : 4.47 (t, 2H, H-2); 3.17 (t, 2H, H-6); 2.72 (t, 2H, H-3); 2.00 (t, 2H, H-5); 4.36 
(s, 2H, -N-CH2-Ph); 4.29 (s, 1H, NH proton) 7.48-7.43 (m, 10H, aryl protons). 
13C NMR (δ ppm) : 48.99 (C-2); 47.84 (C-6); 23.09 (C-3); 19.94 (C-5); 136.41 (C=N); 58.22 (N-
CH2-Ph); 131.30-124.66 (aromatic carbons). 
 
 
In vitro thrombolytic activity of compound N-benzyl 
piperidin-4-one phenyl hydrazone (BPPH) 
Thrombolytic therapy, also known as clot busting drug, is a 
breakthrough treatment which has saved untold lives. It has 
been used in the clinical area to treat venous and arterial 
thromboembolic complaints which are a foremost cause of 
death. 
The in-vitro thrombolytic activity of the BPPH was 
determined by clot lysis study.  The activity of the 
compounds was determined by comparison with the 
thrombolytic activity of Streptokinase. The test compound 
was measured for the decrease in clot weight at different 
concentrations. 
 
 
Table 2: Thrombolytic activity of BPPH  
S.No. Sample % of clot lysis 
1.  Control 25.01±1.75 
2.  Sample (100µl) 53.33±3.71 
3.  Sample (200µl) 77.50±5.39 
4.  Standard 
(Streptokinase) 
83.33±5.81 
 
In the present study, thrombolytic activity analysis of sample 
extract (100µl and 200µl) showed removal of clot by 53.33% 
and 77.50%, respectively, with that of positive Control 
streptokinase (SK) of 83.33% and negative control of 
25.01% clot lysis.  
 
 
Sundaresan et al                                                                                                     Journal of Drug Delivery & Therapeutics. 2019; 9(2):180-182 
ISSN: 2250-1177                                                                                  [182]                                                                                 CODEN (USA): JDDTAO 
The clot lysis at 100 µl 200 µl of compound was 53.33%, 
77.50% in 370c at 45 min respectively while standard shows 
83.33%. The highest dose as 200 µl of compound has 
significant activity and near to the standard. 
 
 
Thrombolytic activity of BPPH 
CONCLUSION 
The structures of the synthesized compound are established 
on the basis of their analytical and spectral data (IR, 1H NMR, 
13C NMR). The result from the study showed that the N-
benzyl piperidin-4-one phenyl hydrazone had excellent 
thrombolytic activity that was comparable to the activity of 
Streptokinase. As from the research findings of the under 
taken in vitro clotlysis study, we demonstrated that the 
compound showed mainly moderate thrombolytic activity. 
Our findings support the reported therapeutic use of this 
compound as clot lysis or thrombolytic agent in the Indian 
system of medicine. 
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